TT SMAD/TGFbeta Reporter (Luc) stable cell line
TT SMAD/TGFbeta Reporter (Luc) cells are derived from the human medullary thyroid carcinoma (MTC) TT cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. TT cells have been widely used for medullary thyroid carcinoma (MTC) research, particularly in studies related to calcitonin production, tumorigenesis, and the development of targeted therapies. Its ability to secrete calcitonin and form tumors in vivo makes it a valuable model for both in vitro and in vivo studies of MTC biology and treatment. TT SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGF?/SMAD signaling pathway.
Product Specifications
No additional specifications available.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TST CRISPRa sgRNA lentivector (set of three targets)(Mouse)
ANKRD20B sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Recombinant Mycobacterium Bovis secA2 Protein (aa 1-808)